bèta
Trial Radar AI
De klinische studie NCT06918795 voor Enkelvoudige ventrikel, Aangeboren hartziekte is recruterend. Bekijk de kaartweergave van de Klinische Studies Radar en de AI-ontdekkingstools voor alle details. Of stel hier een vraag.
Eén studie komt overeen met de filtercriteria
Kaartweergave

Fontan Fitness Trial

Recruterend
Informatie over klinische studies is voornamelijk in het Engels beschikbaar. Trial Radar AI kan echter helpen! Klik op 'Leg studie uit' om de informatie over de studie te bekijken en te bespreken in de taal van uw keuze.
De klinische studie NCT06918795 is een interventioneel studie bij Enkelvoudige ventrikel, Aangeboren hartziekte met de status recruterend. Het doel is om 200 deelnemers te includeren vanaf 9 juni 2025. De studie wordt geleid door Children's Hospital of Philadelphia en de voltooiing is gepland op 1 april 2029. Laatste update op ClinicalTrials.gov: 11 juni 2025.
Beknopte samenvatting

The goal of this randomized control trial is to learn about physical fitness and exercise habits in children aged 10-17 with the Fontan Circulation through a home-based, digital exercise intervention. The main questions it aims to answer are:

  • Does a home-based, digital intervention increase physical activity (PA) in youth with the FC compared to enhanced usual care?
  • Does a home-based, digital intervention increase physical fitness in youth with the FC compared to enhanced usual care?
  • Do multi-level factors (medical, neurodevelopmental, sociodemographic, neighborhood) impact the effectiveness of the digital intervention?

Researchers will compare participants in the enhanced usual care arm to those in the exercise intervention arm to see if the digital intervention is effective.

All participants will wear a PA tracker for 12 months and complete testing at baseline, 6 months, and 12 months.

In addition, participants in the exercise intervention arm will complete a 6-month exercise intervention with the following components:

  • aerobic exercise
  • resistance exercise
  • engagement strategies
Uitgebreide beschrijving
The Fontan Circulation is associated with poor exercise performance and reduced quality of life. Current standard of care encourages physical activity (PA) in this population, but few structured interventions exist. Participants will be randomly assigned to either enhanced usual care (PA tracker and standard encouragement) or an interactive digital intervention that includes personalized aerobic and resistance exercises with behavioral engagement strategies. This study will evaluate a home-based, digital intervention delivered through a mobile health platform to promote PA and improve fitness among youth with FC.

The study will recruit up to 200 participants aged 10-17 years with FC. After initial testing and a two-week run-in period, 120 participants with peak VO2 between 45% and 80% of predicted norms will be randomized. The intervention will last 6 months, followed by a 5.5-month monitoring phase. Outcomes will include changes in PA (measured via accelerometry), peak VO2, muscle strength, body composition, and quality of life.

Officiële titel

Home-based, Digital Intervention to Increase Physical Activity in Patients With the Fontan Circulation

Aandoeningen
Enkelvoudige ventrikelAangeboren hartziekte
Andere studie-ID's
NCT-ID
Startdatum (Werkelijk)
2025-06-09
Laatste update geplaatst
2025-06-11
Verwachte einddatum
2029-04
Inschrijving (Geschat)
200
Studietype
Interventioneel
FASE
N.v.t.
Status
Recruterend
Trefwoorden
Fontan
Single ventricle disease
exercise intervention
digital health
adolescents
randomized control trial
Primaire doel
Behandeling
Toewijzing
Gerandomiseerd
Interventiemodel
Parallel
Blindering
Dubbelblind
Armen / Interventies
Deelnemersgroep/StudiearmInterventie/Behandeling
ExperimenteelDigital Exercise Intervention
The exercise intervention arm includes access to a digital application to receive the following over the 6-month intervention: * personalized plans for aerobic-based PA * personalized resistance exercise sessions * engagement strategies.
Digital Exercise Intervention
Subjects randomized to the intervention arm will receive the same as the enhanced usual care arm but will be additionally exposed to: (1) personalized plans for aerobic-based PA, (2) personalized resistance exercise sessions, and (3) financial and non-financial engagement strategies. These intervention components will be delivered continuously using an advanced digital health informatics platform during the 6 months of the intervention. The intervention will be overseen and supplemented by the exercise physiologist, who will meet with participants on a weekly, then biweekly and finally monthly basis over 6 months.
Geen interventieEnhanced Usual Care
The enhanced usual care arm will receive their usual care in addition to a passive physical activity tracker device. No intervention materials will be delivered to these participants over the course of their enrollment in the study.
N.v.t.
Primaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
MIMS-units
Change in total volume of physical activity (PA) operationalized as a Monitor Independent Movement Summary (MIMS) units, expressed as a percentile based on what is expected for their age and sex.
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
Absolute peak VO2
Change in absolute peak VO2, the maximum amount of oxygen the body consumes during exercise without regard to body weight (liters/minute).
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
Percent predicted peak VO2
Change in percent predicted peak VO2, the maximum amount of oxygen the body consumes during exercise expressed as a percentage of what is expected for their age and sex.
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
Leg lean mass
Change in leg lean mass presented as a z-score. Leg lean mass z-score compares an individual's leg muscle mass to the average for their age and sex, with values below -2.0 indicating lower-than-expected muscle mass.
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
Secundaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
MVPA
Change in time spent in moderate to vigorous physical activity (MVPA), in terms of minutes per day.
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
Forearm strength
Change in forearm strength measured via handgrip test and presented as a z-score. Z-scores are used to standardize measurements across individuals with different demographics (i.e. age, sex, body size).
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
Lower extremity strength
Change in lower extremity strength measured via knee and ankle peak torsion and presented as a z-score.
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
PROMIS Pediatric Profile-25 T-score
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Profile-25. This 25-item questionnaire provides a T-score based on physical function, anxiety, depression, fatigue, peer relationships and pain. Children and parents will complete a PROMIS questionnaire. Children will answer questions about themselves and parents will answer questions in regard to their child.
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
PCQLI score
Change in Pediatric Cardiac Quality of Life Instrument (PCQLI) total and sub-scale scores (i.e. Disease Impact, Psychosocial Impact).The PCQLI is a cardiac-specific health-related quality-of-life instrument. Children will answer questions about themselves and parents will answer questions in regard to their child.
0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months.
Geschiktheidscriteria

Leeftijd van deelnemers
Kind
Minimumleeftijd
10 Years
Geslachten die in aanmerking komen voor de studie
Allen
  • Fontan Circulation present
  • Girls ≥11 years of age or menstruating must have negative urine pregnancy test
  • Neurodevelopmental capacity to complete all study procedures
  • Physical capacity to complete all study procedures
  • English speaking with at least one English speaking parent/guardian
  • To enroll in the randomized control trial, percent predicted peak VO2 <80% of age-sex matched normal controls on the baseline exercise stress test (EST)

  • Inability to complete an EST at any time (i.e. limited physical or executive function)
  • Uncontrolled lymphatic disorders
  • Exercise induced or uncontrolled arrhythmias
  • Pacemaker or internal cardiac defibrillator (ICD)
  • Peak VO2 <45% age-sex predicted
  • Having had or under consideration for a heart transplant
  • Pregnant or lactating females
  • Parents/guardians or subjects who, in the opinion of the investigator, may be non-compliant with study schedules or procedures
Children's Hospital of Philadelphia logoChildren's Hospital of Philadelphia
Centraal Contactpersoon
Contact: Elizabeth Goldmuntz, MD, 215-590-3354, [email protected]
Contact: Zoe Lincoln, MS, [email protected]
1 Studielocaties in 1 landen

Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States
Elizabeth Goldmuntz, MD, Contact, [email protected]
Zoe Lincoln, MS, Contact, [email protected]
Elizabeth Goldmuntz, MD, Hoofdonderzoeker
Jonathan Mitchell, PhD, Subonderzoeker
Recruterend